NSF ACCESS: New Frontiers in Precision Medicine
July 13, 2026 — Have you ever taken a prescribed medicine to resolve a health issue, only for the treatment to fail? Perhaps you’re among the unlucky low percentage of people on weight loss drugs who…
Read the full articleYou might also wanna read
A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With Obesity
Conditions : Obesity; Elevated High-sensitivity C-reactive Protein (hsCRP) Interventions : Drug: NNC6022-0004; Drug: Placebo Sponsors : Novo
CME | Slim Solutions: Navigating Weight Loss Medications
The CME on the Go series of the Inside Family Medicine podcast lets you earn up to 0.5 CME credits per episode — join the hosts as they dive
Daily briefing: The rise of evidence-based medicine
Nature, Published online: 13 July 2026; doi:10.1038/d41586-026-02206-z How rigorous research has transformed health and social policy. Plus,
Most Weight-Loss Drugs Do Not Improve Quality of Life or Heart Health
A new study found that while several newer weight loss medications can help with significant weight loss, they do not improve quality of lif
Meta-analysis of 19 Weight-Loss Drugs Finds No Meaningful Cardiovascular or Quality-of-Life Benefits
A network meta-analysis of 19 weight-loss drugs concludes that most obesity drugs don’t improve quality of life or cardiovascular health.
The Quiet Revolution in Precision Medicine
From beans for men's hearts to proteins that block cancer spread, researchers worldwide are cracking diseases open with unprecedented precis

Comments
Sign in to join the conversation.
No comments yet. Be the first.